Wellington Management Group
FHTX icon

Wellington Management Group’s Foghorn Therapeutics FHTX Stock Holding History

Wellington Management Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-118,342
Closed -$556K – 2015
2025
Q2 		$556K Buy
118,342
+15,454
+15% +$64.6K ﹤0.01% 1809
2025
Q1 		$376K Buy
102,888
+15,819
+18% +$72.1K ﹤0.01% 1858
2024
Q4 		$411K Buy
87,069
+14,853
+21% +$108K ﹤0.01% 1849
2024
Q3 		$672K Buy
72,216
+28,427
+65% +$206K ﹤0.01% 1778
2024
Q2 		$252K Buy
+43,789
New +$261K ﹤0.01% 1843

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Wellington Management Group's FHTX Position: Q3 2025 in Review

Wellington Management Group sold out of Foghorn Therapeutics (FHTX) in Q3 2025, closing a stake of 118,342 shares — an estimated $556K sold.

Wellington Management Group first reported a position in FHTX in Q2 2024 and held it in 5 quarters. The position peaked at $672K in Q3 2024. 88 funds tracked by Wall St. Rank hold FHTX as of Q3 2025.

  • Wellington Management Group reported no remaining Foghorn Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 118,342 Foghorn Therapeutics shares in Q3 2025, an estimated $556K.
  • Wellington Management Group first reported a position in Foghorn Therapeutics in Q2 2024 and held it in 5 quarters.
  • Wellington Management Group's Foghorn Therapeutics position peaked at $672K in Q3 2024.
  • 88 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.